Article Versions Notes

Macias RIR, Muñoz-Bellvís L, Sánchez-Martín A, Arretxe E, Martínez-Arranz I, Lapitz A, Gutiérrez ML, La Casta A, Alonso C, González LM, et al. A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Cancers. 2020; 12(6):1433. https://doi.org/10.3390/cancers12061433

Macias, Rocio I. R., Luis Muñoz-Bellvís, Anabel Sánchez-Martín, Enara Arretxe, Ibon Martínez-Arranz, Ainhoa Lapitz, M. Laura Gutiérrez, Adelaida La Casta, Cristina Alonso, Luis M. González, and et al. 2020. "A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma" Cancers 12, no. 6: 1433. https://doi.org/10.3390/cancers12061433

Macias, R. I. R., Muñoz-Bellvís, L., Sánchez-Martín, A., Arretxe, E., Martínez-Arranz, I., Lapitz, A., Gutiérrez, M. L., La Casta, A., Alonso, C., González, L. M., Avila, M. A., Martinez-Chantar, M. L., Castro, R. E., Bujanda, L., Banales, J. M., & Marin, J. J. G. (2020). A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Cancers, 12(6), 1433. https://doi.org/10.3390/cancers12061433